Chunliang Shang

Beijing University of Chemical Technology

H指数:16

被引数:958

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Insights into Active Sites of Dehydrogenation–Condensation–Dehydration Steps in Ethanol-to-1,3-Butadiene Conversion over Tailored MgO–SiO2 Catalysts

在定制MgO–SiO2催化剂上乙醇转化为1,3-丁二烯过程中脱氢-缩合-脱水步骤活性位点的见解

ACS Omega

IF4.3

2026-08-250

PRE

Self-illuminating activatable chemotherapy enabled by pH-MPO-ROS cascade-amplified nanoparticles for cancer and metastatic lymph nodes

基于pH-MPO-ROS级联放大纳米粒子的自发光激活化疗，用于治疗癌症及转移性淋巴结

Nano Today

IF10.9

2026-03-260

PRE

Lymph Node Preservation as an Immunotherapeutic Catalyst

Critical Reviews in Oncology/Hematology

IF0

2026-02-060

OAAI

GALNT10 Affects O-Glycosylation of IGFBP7 to Promote Tumor Vascular Remodeling and Metastasis of Ovarian Cancer

Advanced Science

IF14.1

2026-02-040

OAAI

A multidimensional data-driven approach to surgical plan optimization and postoperative residual tumor prediction in ovarian cancer

一种多维数据驱动的方法用于卵巢癌的手术计划优化和术后残余肿瘤预测

Frontiers in Immunology

IF5.9

2025-12-170

OAAI

Decoding ascitic immunological niches with multi-modal machine learning reveals prognostic and chemoresistant determinants in ovarian cancer

FRONTIERS IN IMMUNOLOGY

IF5.9

2025-12-030

Composite score of PD-1+CD8+ tumor-infiltrating lymphocytes and CD57+CD8+ tumor ascites lymphocytes is associated with prognosis and tumor immune microenvironment of patients with advanced high-grade serous ovarian cancer

PD-1+CD8+肿瘤浸润淋巴细胞和CD57+CD8+肿瘤腹水淋巴细胞的复合评分与晚期高级别浆液性卵巢癌患者的预后及肿瘤免疫微环境相关

CHINESE JOURNAL OF CANCER RESEARCH

IF6.3

2025-01-010

A Tumor-Activatable Liposomal Nanoprobe for Selective Visualization of Metastatic Lymph Nodes

用于选择性可视化转移性淋巴结的肿瘤可激活脂质体纳米探针

ADVANCED HEALTHCARE MATERIALS

IF9.6

2024-08-050

PRE

Fully integrated point-of-care blood cell count using multi-frame morphology analysis

BIOSENSORS & BIOELECTRONICS

IF10.5

2023-03-013

PRE

Associations of novel serum lipid index with epithelial ovarian cancer chemoresistance and prognosis

新型血脂指标与上皮性卵巢癌化疗耐药及预后的关系

FRONTIERS IN ONCOLOGY

IF3.3

2023-02-135

OAAI

Ascitic Senescent T Cells Are Linked to Chemoresistance in Patients With Advanced High-Grade Serous Ovarian Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2022-07-078

OAAI

FASN promotes lymph node metastasis in cervical cancer via cholesterol reprogramming and lymphangiogenesis

FASN通过胆固醇重编程和淋巴管生成促进宫颈癌淋巴结转移

CELL DEATH & DISEASE

IF9.6

2022-05-2158

OAAI

The prognostic miR-532-5p-correlated ceRNA-mediated lipid droplet accumulation drives nodal metastasis of cervical cancer

ceRNA介导的脂滴积累驱动宫颈癌淋巴结转移的预后miR-532-5p-correlated

JOURNAL OF ADVANCED RESEARCH

IF13

2022-03-0125

OAAI

Roles of Pyroptosis-Related Gene Signature in Prediction of Endometrial Cancer Outcomes

FRONTIERS IN MEDICINE

IF3

2022-03-0112

OAAI

Downregulation of LNMAS orchestrates partial EMT and immune escape from macrophage phagocytosis to promote lymph node metastasis of cervical cancer

ONCOGENE

IF7.3

2022-02-1228

OAAI

Circular RNA hsa_circ_0043280 inhibits cervical cancer tumor growth and metastasis via miR-203a-3p/PAQR3 axis

CELL DEATH & DISEASE

IF9.6

2021-09-2936

OAAI

Development of a Genomic Signatures-Based Predictor of Initial Platinum-Resistance in Advanced High-Grade Serous Ovarian Cancer Patients

基于基因组特征的晚期高级别浆液性卵巢癌患者初始铂类耐药预测指标的开发

FRONTIERS IN ONCOLOGY

IF3.3

2021-03-0512

OAAI

The dynamic behavior of lipid droplets in the pre-metastatic niche

CELL DEATH & DISEASE

IF9.6

2020-11-179

OAAI

DSG2 expression is correlated with poor prognosis and promotes early-stage cervical cancer

CANCER CELL INTERNATIONAL

IF6

2020-06-0332

OAAI

High Expression of Integrin α3 Predicts Poor Prognosis and Promotes Tumor Metastasis and Angiogenesis by Activating the c-Src/Extracellular Signal-Regulated Protein Kinase/Focal Adhesion Kinase Signaling Pathway in Cervical Cancer

FRONTIERS IN ONCOLOGY

IF3.3

2020-02-1427

OAAI

Chunliang Shang

个人简介

教育背景

工作经历

荣誉奖项

研究方向